Ribociclib

Category: Cancer



Ribociclib Overview

Ribociclib (trade name Kisqali[1]) is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer.[2] It is also being studied as a treatment for other drug-resistant cancers.[3] It was developed by Novartis and Astex Pharmaceuticals.[4] Contents 1 Medical uses 2 Side effects 3 Interactions 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 5 Research 6 Chemistry 7 See ...

Read more Ribociclib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ribociclib

Recent Ribociclib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ribociclib
  • Tablet: 200mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ribociclib or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA